WO2007143526A3 - Substituted tetrahydroimidazonaphthyridines and methods - Google Patents
Substituted tetrahydroimidazonaphthyridines and methods Download PDFInfo
- Publication number
- WO2007143526A3 WO2007143526A3 PCT/US2007/070181 US2007070181W WO2007143526A3 WO 2007143526 A3 WO2007143526 A3 WO 2007143526A3 US 2007070181 W US2007070181 W US 2007070181W WO 2007143526 A3 WO2007143526 A3 WO 2007143526A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- compounds
- tetrahydroimidazonaphthyridines
- substituted
- naphthyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
6,7,8,9-Tetrahydro-1H-imidazo[4,5-c]naphthyridines with a substituent at the 6-, 7-, 8-, or 9-position nitrogen atom, pharmaceutical compositions containing these compounds, methods of making the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80392706P | 2006-06-05 | 2006-06-05 | |
US60/803,927 | 2006-06-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007143526A2 WO2007143526A2 (en) | 2007-12-13 |
WO2007143526A3 true WO2007143526A3 (en) | 2008-02-07 |
Family
ID=38802237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/070181 WO2007143526A2 (en) | 2006-06-05 | 2007-06-01 | Substituted tetrahydroimidazonaphthyridines and methods |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007143526A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007502293A (en) | 2003-08-12 | 2007-02-08 | スリーエム イノベイティブ プロパティズ カンパニー | Hydroxylamine-substituted imidazo-containing compounds |
EP1658076B1 (en) | 2003-08-27 | 2013-03-06 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
CA2537763A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
AR046046A1 (en) | 2003-10-03 | 2005-11-23 | 3M Innovative Properties Co | IMIDAZOQUINOLINAS ALCOXI SUBSTITUTED. PHARMACEUTICAL COMPOSITIONS. |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
CA2545774A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Oxime substituted imidazo ring compounds |
CA2545825A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
BRPI0416936A (en) | 2003-11-25 | 2007-01-16 | 3M Innovative Properties Co | substituted imidazo ring systems and methods |
EP1701955A1 (en) | 2003-12-29 | 2006-09-20 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
EP1699788A2 (en) | 2003-12-30 | 2006-09-13 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides |
AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
WO2005123080A2 (en) | 2004-06-15 | 2005-12-29 | 3M Innovative Properties Company | Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
JP5543068B2 (en) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | Chiral fused [1,2] imidazo [4,5-c] cyclic compound |
US8034938B2 (en) | 2004-12-30 | 2011-10-11 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
EP1846405A2 (en) | 2005-02-11 | 2007-10-24 | 3M Innovative Properties Company | Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods |
US7943610B2 (en) | 2005-04-01 | 2011-05-17 | 3M Innovative Properties Company | Pyrazolopyridine-1,4-diamines and analogs thereof |
CA2602590A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
WO2008008432A2 (en) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
JP6873980B2 (en) * | 2015-09-14 | 2021-05-19 | ファイザー・インク | Novel imidazole [4,5-c] quinoline and imidazole [4,5-c] [1,5] naphthylidine derivatives as LRRK2 inhibitors |
US20220306633A1 (en) * | 2021-03-22 | 2022-09-29 | Incyte Corporation | Imidazole and triazole kras inhibitors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194425B1 (en) * | 1997-12-11 | 2001-02-27 | 3M Innovative Properties Company | Imidazonaphthyridines |
US6518280B2 (en) * | 1998-12-11 | 2003-02-11 | 3M Innovative Properties Company | Imidazonaphthyridines |
US20040147543A1 (en) * | 2002-12-20 | 2004-07-29 | 3M Innovative Properties Company | Aryl substituted imidazoquinolines |
-
2007
- 2007-06-01 WO PCT/US2007/070181 patent/WO2007143526A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194425B1 (en) * | 1997-12-11 | 2001-02-27 | 3M Innovative Properties Company | Imidazonaphthyridines |
US6518280B2 (en) * | 1998-12-11 | 2003-02-11 | 3M Innovative Properties Company | Imidazonaphthyridines |
US20040147543A1 (en) * | 2002-12-20 | 2004-07-29 | 3M Innovative Properties Company | Aryl substituted imidazoquinolines |
Also Published As
Publication number | Publication date |
---|---|
WO2007143526A2 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007143526A3 (en) | Substituted tetrahydroimidazonaphthyridines and methods | |
MX2008002414A (en) | Hydroxy substituted 1h-imidazopyridines and methods. | |
WO2005032484A3 (en) | Alkoxy substituted imidazoquinolines | |
WO2007056112A3 (en) | Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods | |
WO2006086633A3 (en) | Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods | |
WO2006086449A3 (en) | Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines | |
WO2006093514A3 (en) | Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines | |
WO2005123080A3 (en) | Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines | |
WO2007106854A3 (en) | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods | |
WO2006107771A3 (en) | PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS | |
WO2005018556A3 (en) | Hydroxylamine substituted imidazo-containing compounds | |
WO2006107853A3 (en) | Pyrazolopyridine-1,4-diamines and analogs thereof | |
WO2008030511A3 (en) | Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes | |
WO2007106852A3 (en) | Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods | |
MY145983A (en) | Aryloxy and arylalkyleneoxy substituted imidazoquinolines | |
WO2006107753A3 (en) | Pyrazolopyridines and analogs thereof | |
WO2005048945A3 (en) | Hydroxylamine substituted imidazo ring compounds | |
WO2005123079A3 (en) | Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines | |
WO2005079195A3 (en) | Pyrazolopyridines and analogs thereof | |
WO2005094531A3 (en) | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines | |
WO2006038923A3 (en) | Aryl substituted imidazonaphthyridines | |
WO2005048933A3 (en) | Oxime substituted imidazo ring compounds | |
WO2006091647A3 (en) | Method of preferentially inducing the biosynthesis of interferon | |
WO2006026760A3 (en) | 1-amino imidazo-containing compounds and methods | |
WO2006086634A3 (en) | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07797985 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07797985 Country of ref document: EP Kind code of ref document: A2 |